Studies: ATO + ATRA vs. Chemotherapie + ATRA

ID Trial

APL 0406

Clinicaltrials.gov identifier

NCT00482833

Description

A randomised phase III study to compare arsenic trioxide (ATO= combined to ATRA versus standard ATRA and anthracycline-based chemotherapy (AIDA regimen) for newly diagnosed, noch high-risk acute promyelocytic leukemia

Status

closed

Disease

Disease Stage  
acute promyelocytic leukemia intermediate risk
low risk

Treatment arms

Name Description  
A ATRA + ATO
B AIDA

Coordinating investigator

No data

Principal investigator

Prof. Dr. A. Ganser
Medizinische Hochschule Hannover
Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
Carl-Neuberg-Str. 1
30625 Hannover
Germany

Study nurse

G. Samson
Medizinische Hochschule Hannover
Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
Carl-Neuberg-Str. 1
30625 Hannover
Germany
Phone: 0511 532-9321
Fax: 0511 532-8321
Pager: 74-3273
Email samson.gabriele@mh-hannover.de